Homozygosity mapping of achromatopsia to chromosome 2 using DNA pooling

Achromatopsia is an autosomal recessive disease of the retina, characterized clinically by an inability to distinguish colors, impaired visual acuity, nystagmus and photophobia. A genome-wide search for linkage was performed using an inbred Jewish kindred from Iran. To facilitate the genome-wide search, we utilized a DNA pooling strategy which takes advantage of the likelihood that the disease in this inbred kindred is inherited by all affected individuals from a common founder. Equal molar amounts of DNA from all affected individuals were pooled and used as the PCR template for short tandem repeat polymorphic markers (STRPs). Pooled DNA from unaffected members of the kindred was used as a control. A reduction in the number of alleles in the affected versus control pool was observed at several loci. Upon genotyping of individual family members, significant linkage was established between the disease phenotype and markers localized on chromosome 2. The highest LOD score observed was 5.4 (theta = 0). When four additional small unrelated families were genotyped, the combined peak LOD score was 8.2. Analysis of recombinant chromosomes revealed that the disease gene lies within a 30 cM interval which spans the centromere. Additional fine-mapping studies identified a region of homozygosity in all affected individuals, narrowing the region to 14 cM. A candidate gene for achromatopsia was excluded from this disease interval by radiation hybrid mapping. Linkage of achromatopsia to chromosome 2 is an essential first step in the identification of the disease-causing gene.      

Pharmacokinetics of tolfenamic acid in patients with cirrhosis of the liver

Summary Six patients with alcoholic cirrhosis of the liver received 100 mg tolfenamic acid p.o. and i.v. The disposition of tolfenamic acid could be described by a two-compartment open body model, with a mean central compartment volume of 8.71, and a -phase volume of 251. The elimination rate constant k_e averaged 1.13 h^–1 and the half-life of the -phase was 1.73 h; the mean total plasma clearance was 159 ml/min. These pharmacokinetic parameters differed only slightly from those in two groups of healthy volunteers studied previously; k_e was significantly reduced by about 30% in the patients but none of the other parameters differed significantly. There was good correlation between individual elimination rate constants or plasma clearances with the liver function tests, serum albumin and P-coagulation factors. Oral absorption was good and bioavailability of about 100% was shown by comparison of the areas under the plasma concentration — time curves after i.v. and p.o. administration. Metabolism was qualitatively and quantitatively very similar to previous observations in healthy volunteers. There seems no reason to reduce the dose of tolfenamic acid in patients with compensated alcoholic cirrhosis.     

In vivo expression of the B7 costimulatory molecule by subsets of antigen-presenting cells and the malignant cells of Hodgkin's disease

The B-lymphocyte/accessory-cell activation antigen B7 (BB1) has been shown in vitro to stimulate T-lymphocyte proliferation and cytokine production via CD28 present on the latter cells. In this study, benign lymphoid tissues, lymphomas, and extralymphoid inflammatory sites were examined immunohistochemically using anti-B7 and other relevant monoclonal antibodies. B7 was expressed by benign transformed germinal center B cells, as it was by B cells of follicular lymphomas. B7 was also expressed by a subpopulation (a mean of 31% to 65%) of macrophages and dendritic cells in a variety of lymphoid tissues. It was present in abundance on all macrophages constituting sarcoid granulomas in lymph nodes. In extralymphoid inflammation, 17% to 35% of macrophages expressed B7 only weakly. Cases of Hodgkin's disease showed expression of B7 by the majority of Reed-Sternberg cells or malignant mononuclear variants, a phenomenon that potentially contributes to the lymphocytic accumulation that is a feature of this condition. CD28+ T cells were seen in all areas where T cells were present. B7+ and CD28+ cells colocalized in, for example, lymphoid follicles, lymph node paracortex, sarcoid granulomas, and Hodgkin's disease tissue, indicating a potential for cellular interaction via these molecules at these sites.     

Cytopathic effects of chum salmon reovirus to salmonid epithelial, fibroblast and macrophage cell lines

The cytopathic effect (CPE) of chum salmon reovirus (CSV), an aquareovirus, was studied in three salmonid cell lines: epithelial-like CHSE-214 from Chinook salmon embryo, fibroblast-like RTG-2, and monocyte/macrophage-like RTS11, both from rainbow trout. CHSE-214 and RTG-2 supported syncytia formation with more dramatic syncytia being observed in CHSE-214 cultures, while CSV induced homotypic aggregation (HA) in RTS11. Syncytia and HA formation were blocked by cycloheximide and ribavirin but not actinomycin D, suggesting that expression of CSV genes were required for both phenomena. Cultures with syncytia underwent a decline in cell viability, which appeared to be via apoptosis, as determined by intranucleosomal fragmentation and caspase dependence assays using the pan-caspase inhibitor, zVAD-fmk. In the presence of zVAD-fmk, CHSE-214 cultures continued to form syncytia and show diminished energy metabolism, but DNA fragmentation, the loss of membrane integrity, and the release of infectious CSV were considerably blocked. These results suggest that the formation of syncytia triggers apoptosis and a leaky plasma membrane, which enhances viral release. By contrast, RTS11 cultures undergoing HA showed no loss of cell viability. The significance of HA is unclear, but the response suggests that macrophage behaviour in rainbow trout potentially could be modulated by CSV.     

Induction of rainbow trout MH class I and accessory proteins by viral haemorrhagic septicaemia virus

Major histocompatibility (MH) class I receptors are glycoproteins which play a critical role during responses to intracellular pathogens by presenting endogenous peptides to cytotoxic T cell lymphocytes (CD8+). To date, little is known about MH class I regulation at the protein level during viral infections in fish. In this study, we characterised the MH class I pathway response to polyinosinic–polycytidylic acid (poly I:C) and upon infection with viral haemorrhagic septicemia virus (VHSV) genotype IVa using the rainbow trout monocyte/macrophage cell line RTS11. A 14-day challenge with VHSV IVa at 14 °C demonstrated enhanced expression of the class I heavy chain, β2 microglobulin (β2M) and tapasin, while the expression of other accessory molecules ERp57 and calreticulin remained unchanged. However, when infection occurred at 2 °C no change in expression levels of any of these molecules was observed. β2M accumulated in the media of RTS11 over time, however the β2M concentrations were 2 fold higher in cultures infected with VHSV 14 days post infection. Strikingly, when cells were maintained at 2 °C the secretion of β2M was significantly reduced in both infected and non-infected cultures. These results indicate that VHSV infection alters the kinetics of β2M release as well as the expression of MH class I and suggests that cellular immunity against VHSV can be compromised at low temperatures which may increase host susceptibility to this virus during the winter.     

Optical properties of rainbow trout lenses after in vitro exposure to polycyclic aromatic hydrocarbons in the presence or absence of ultraviolet radiation

The optical properties of rainbow trout lenses were investigated after in vitro exposure to polycyclic aromatic hydrocarbons (PAHs) and ultraviolet (UV) irradiation, both because PAHs frequently contaminate aquatic environments and because UV exposure has generally increased with the decline of the ozone layer. Lenses were exposed to UV irradiation for 12 hr while immersed in culture medium. UV irradiation, with or without the presence of PAHs, was accomplished with one UVA and one UVB photoreactor lamp to yield a photon fluence rate of 9.27 micromol m(-2)s(-1)UVA (UVA:UVB 10.8, radiant exposure of 13.4 Jcm(-1)). Individual PAHs studied were fluorene, fluoranthene and benzo(a)pyrene. In addition, lenses were exposed to a solution of creosote, a wood preservative used in the aquatic environment that contains many PAHs. All PAH exposures, including creosote, were carried out either in the dark or concurrently with UV irradiation. A scanning laser monitor system was used to evaluate the optical properties of lenses for up to 236 hr after the UV/PAH treatments. Mean focal length variability (FLV) increased with time after concurrent exposure to UV irradiation and high concentrations of either fluoranthene (4900 n m), benzo(a)pyrene (265 n m) or creosote (70 microg ml(-1)), with FLV values ranging from, 0.21-0.41, 0.21-0.64 and 0.15-0.22 mm, respectively, 72 hr after termination of the UV/PAH treatment. UV irradiation alone or exposure to PAHs in the dark brought about no changes in the optical properties of lenses. Also, fluorene in the presence or absence of UV had no effect, even at concentrations as high as 128 microm. Lenses were also unchanged by 12 hr exposures in the dark to solutions of either fluorene, fluoranthene, benzo(a)pyrene or creosote that had been previously UV irradiated for 12 hr. This meant that photomodified products of the individual PAHs or creosote were not cataractogenic and emphasized that simultaneous exposure to UV and PAHs or creosote was necessary for the increased FLV. The results point for the first time to an interaction between UV irradiation and PAHs as a potential contributing factor to cataract formation in fish.     

Standards for total body fat and fat-free mass in infants

Data on body composition in conjunction with reference centiles are helpful in identifying the severity of growth and nutritional disorders in infancy and for evaluating the adequacy of treatment given during this important period of rapid growth. Total body fat (TBF) and fat-free mass (FFM) were estimated from total body electrical conductivity (TBEC) measurements in 423 healthy term Caucasian infants, aged 14-379 days. Cross sectional age, weight, and length related centile standards are presented for TBF and FFM. Centiles were calculated using Altman's method, based on polynomial regression and modelling of the residual variation. The TBF percentage steeply increased during the first half year of life, and slowly declined beyond this age. Various simple TBEC derived anthropometric prediction equations for TBF and FFM are available to be used in conjunction with these standards. Regression equations for the P50 and the residual SD, depending on age, weight, or length, are provided for constructing centile charts and calculating standard deviation scores.